Search
for
Sort by
Research 61–90 of 1000+
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial
- Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma
- Male sex hormones, aging, and inflammation
- Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor‐β2/insulin‐like growth factor‐1‐mediated regulation of the hair cycle in male and female human hair follicles<i>in vitro</i>
- Male pattern hair loss: current understanding
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Dissection of genetic variation and evidence for pleiotropy in male pattern baldness
- Dose-response study of topical minoxidil in male pattern baldness
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals
- Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment
- C<sub>19</sub>and C<sub>21</sub>5<i>β</i>/5<i>α</i>Metabolite Ratios in Subjects Treated with the 5<i>α</i>-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5<i>α</i>-Reductase Deficiency*
- Male androgenetic alopecia
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- Use of topical minoxidil in the treatment of male pattern baldness
- Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia
- Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men
- Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Long-term follow-up of men with male pattern baldness treated with topical minoxidil
- A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
- Fractional Photothermolysis Laser Treatment of Male Pattern Hair Loss
- Treatment of Male Pattern Baldness with Botulinum Toxin: A Pilot Study
- Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men
- Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat
- Evaluation of DNA Variants Associated with Androgenetic Alopecia and Their Potential to Predict Male Pattern Baldness
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern Baldness